- Home
- CEV vs ZTEK Comparison
CEV vs ZTEK Comparison
Compare CEV & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEV
- ZTEK
- Stock Information
- Founded
- CEV 1999
- ZTEK 2008
- Country
- CEV United States
- ZTEK Canada
- Employees
- CEV N/A
- ZTEK N/A
- Industry
- CEV Finance/Investors Services
- ZTEK Major Chemicals
- Sector
- CEV Finance
- ZTEK Industrials
- Exchange
- CEV Nasdaq
- ZTEK Nasdaq
- Market Cap
- CEV 70.8M
- ZTEK 81.7M
- IPO Year
- CEV N/A
- ZTEK N/A
- Fundamental
- Price
- CEV $10.20
- ZTEK $0.90
- Analyst Decision
- CEV
- ZTEK
- Analyst Count
- CEV 0
- ZTEK 0
- Target Price
- CEV N/A
- ZTEK N/A
- AVG Volume (30 Days)
- CEV 19.6K
- ZTEK 136.6K
- Earning Date
- CEV 01-01-0001
- ZTEK 11-13-2025
- Dividend Yield
- CEV 4.23%
- ZTEK N/A
- EPS Growth
- CEV N/A
- ZTEK N/A
- EPS
- CEV 0.36
- ZTEK N/A
- Revenue
- CEV N/A
- ZTEK $678,078.00
- Revenue This Year
- CEV N/A
- ZTEK N/A
- Revenue Next Year
- CEV N/A
- ZTEK N/A
- P/E Ratio
- CEV $29.36
- ZTEK N/A
- Revenue Growth
- CEV N/A
- ZTEK 2519.47
- 52 Week Low
- CEV $8.83
- ZTEK $0.62
- 52 Week High
- CEV $10.91
- ZTEK $1.84
- Technical
- Relative Strength Index (RSI)
- CEV 63.01
- ZTEK 58.96
- Support Level
- CEV $10.10
- ZTEK $0.75
- Resistance Level
- CEV $10.30
- ZTEK $0.81
- Average True Range (ATR)
- CEV 0.09
- ZTEK 0.08
- MACD
- CEV -0.01
- ZTEK 0.01
- Stochastic Oscillator
- CEV 66.67
- ZTEK 69.84
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.